JCPSLP Vol 17 No 2 2015_web

39 / 60

JCPSLP Volume 17, Number 2 2015 93
Scheile, J. T., Quinzler, R., Klimm, H., Pruszydlo, M. G., &
Hefeli, W. E. (2013). Difficulties swallowing solid oral dosage
forms in a general practice population: Prevalence, causes,
and relationship to dosage forms. European Journal of
Clinical Pharmacology , 69, 937–948.
Singh, J., Philip, A.K., & Pathak, K. (2008). Optimization
studies on design and evaluation of orodispersible pediatric
formulation of indomethacin. AAPS PharmSciTech 9(1), 60–66.
References
de Groen, P. C. Lubbe, D. F., Hirsch, L. J., Daifotis, A.,
Stephenson, W., Freedholm, D., & Wang, K. K., (1996).
Esophagitis associated with the use of alendronate. New
England Journal of Medicine, 335(14), 1016–1021.
Gallagher, L., & Naidoo, P. (2009). Prescription drugs and
their effects on swallowing. Dysphagia, 24(2), 159–66.
Gurwitz, J. H., Field, T. S., Harrold, L. R., & Rothschild, J.
(2003). Incidence and preventability of adverse drug events
among older persons in the ambulatory setting. JAMA,
289(9), 1107–1116.
Marquis, J., Schneider, M., Payot, V., Cordonier, A.,
Bugon, O., Hersberger, K.E., & Arnet, I. (2013). Swallowing
difficulties with oral drugs among polypharmacy patients
attending community pharmacies. International Journal of
Clinical Pharmacy, 35, 1130–1136.
Nunn, T., & Williams, J. (2005). Formulation of medicines
for children. British Journal of Clinical Pharmacology, 59(6)
674–676.
Emily Davis is the manager of speech pathology at the Bathurst
Health Service in New South Wales, and works primarily with acute
and rehabilitation patients with swallowing and communication
difficulties. Derek Kay is the director of pharmacy at the Bathurst
Health Service.
Correspondence to:
Emily Davis
Bathurst Health Service
email: